Capturing the efficiency of vibrating mesh nebulizers: Minimizing upper airway deposition

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 27, Issue 5, 2014, Pages 341-348

  Sagalla, Rex B ^a   Smaldone, Gerald C ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

aerosol; breath actuation; chamber; respirable fraction; respirable mass

Indexed keywords

SODIUM CHLORIDE; BRONCHODILATING AGENT;

AEROSOL; ARTICLE; BREATHING PATTERN; CASCADE IMPACTOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; EQUIPMENT DESIGN; FILTER; GAMMA CAMERA; HUMAN; HYPERPNEA; IN VITRO STUDY; ISOTOPE LABELING; LABORATORY DEVICE; MEDICAL NEBULIZER; PARTICLE SIZE; UPPER RESPIRATORY TRACT; VENTILATOR; VIBRATING MESH NEBULIZER; BIOLOGICAL MODEL; BREATHING MECHANICS; INHALATION; LUNG; NEBULIZER; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCINTISCANNING; STANDARDS; TIDAL VOLUME; TIME;

BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; HUMANS; IN VITRO TECHNIQUES; INHALATION; LUNG; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIONUCLIDE IMAGING; RESPIRATORY MECHANICS; TIDAL VOLUME; TIME FACTORS;

EID: 84907908041     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2014.1152     Document Type: Article

References (17)

1. Newman S, and Gee-Turner A: The Omron MicroAir vibrating mesh technology nebuliser, a 21st century approach to inhalation therapy. J Appl Ther Res. 2005;5:29-33.
2. Ilowite JS, Baskin MI, Sheetz MS, and Abd AG: Delivered dose and regional distribution of aerosolized pentamidine using different delivery systems. Chest. 1991;99:1139-1144.
3. O'Riordan TG, Palmer LB, and Smaldone GC: Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med. 1994;149: 214-219.
4. Labiris NR, and Dolovich MB: Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:600-612.
5. Skaria S, and Smaldone G: Omron NE U22: comparison between vibrating mesh and jet nebulizer. J Aerosol Med Pulm Drug Deliv. 2010;23:173-180.
6. Diaz KT, Skaria S, Harris K, Solomita M, Lau S, Bauer K, Smaldone GC, and Condos R: Delivery and safety of inhaled interferon-c in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv. 2012;25:79-87.
7. Sangwan S, Condos R, and Smaldone GC: Lung deposition and respirable mass during wet nebulization. J Aerosol Med. 2003;16:379-386.
8. Smaldone G, and Solomita M: Predicting in vivo deposition in vitro. J Aerosol Med Pulm Drug Deliv. 2009;22:9-10.
9. Solomita M, and Smaldone GC: Reconciliation of cascade impaction during wet nebulization. J Aerosol Med Pulm Drug Deliv. 2009;22:11-18.
10. mTc-DTPA. J Aerosol Med Pulm Drug Deliv. 2010;23 Suppl 1:S37-S43.
11. Smaldone GC, Diot P, Groth M, and Ilowite J: Respirable mass: vague and indefinable in disease. J Aerosol Med. 1998;11 Suppl 1:S105-S111.
12. Nektar. NKTR-061 (Amikacin Inhale): Highly Concentrated Lung Delivery. 2008 R&D Day, New York November 12, 2008. Available at: http://library.corporate-ir.net/library/72/721/72130/items/315528/COMBINED R&D DAY DECK FOR WEB v5.pdf, p. 22. Accessed July 17, 2014.
13. Vecellio L, Chantrel G, and Diot P: In vitro evaluation of a novel inhalation chamber for nebulizers and MDI (Idehaler). 2005. Available at: www.aerodrug.com/sites/aerodrug/IMG/pdf/Vecellio-ISAM2005.pdf. Accessed July 17, 2014.
14. Lemarie E, Vecellio L, Hureaux J, Prunier C, Valat C, Grimbert D, Boidron-Celle M, Giraudeau B, le Pape A, Pichon E, Diot P, el Houfia A, and Gagnadoux F: Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. J Aerosol Med Pulm Drug Deliv. 2011;24:261-270.
15. Corkery K, Gribben D, Fink J, Eldon M, and Niederman M: Evidence of High Amikacin Lung Deposition in Mechanically Ventilated Patients (MVP) with Pneumonia and Healthy Subjects (HS) Dosed Using NKTR-061 2008. Available at: www.nektar.com/pdf/pipeline/NKTR-061/Corkery-Phase2ClinicalData-ATS2008.pdf
16. Smaldone GC, Fuhrer J, Steigbigel RT, and McPeck M: Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1991;143:727-737.
17. Smaldone GC, Perry RJ, and Deutsch DG: Characteristics of nebulizers used in the treatment of AIDS-related Pneumocystis carinii pneumonia. J Aerosol Med. 1988;1:113-126.